Notably, an additional caveat for the use of CP itself as biomarker for bacterial infections is the finding that high concentrations of CP may also be detected in plasma of patients with severe viral infections such as COVID 19 due to high amounts of immature neutrophils released from the bone marrow [53]. This evidence concerns the gene CP and bacterial infectious disease.